RJA
CANO

Raymond James & Associates’s Cano Health, Inc. CANO Stock Holding History

Raymond James & Associates’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,166
Closed -$29.6K – 4007
2023
Q3 		$29.6K Buy
1,166
+341
+41% +$28K ﹤0.01% 3707
2023
Q2 		$115K Sell
825
-99
-11% -$12.7K ﹤0.01% 3603
2023
Q1 		$84K Sell
924
-336
-27% -$45.6K ﹤0.01% 3677
2022
Q4 		$173K Sell
1,260
-54
-4% -$18.3K ﹤0.01% 3506
2022
Q3 		$1.14M Buy
1,314
+136
+12% +$85.2K ﹤0.01% 2313
2022
Q2 		$516K Sell
1,178
-78
-6% -$40.7K ﹤0.01% 2896
2022
Q1 		$798K Buy
1,256
+136
+12% +$85.7K ﹤0.01% 2746
2021
Q4 		$998K Buy
1,120
+134
+14% +$141K ﹤0.01% 2621
2021
Q3 		$1.25M Buy
986
+820
+494% +$994K ﹤0.01% 2429
2021
Q2 		$201K Sell
166
-4
-2% -$5.39K ﹤0.01% 3685
2021
Q1 		$225K Buy
170
+35
+26% +$49.6K ﹤0.01% 3540
2020
Q4 		$181K Buy
+135
New +$154K ﹤0.01% 3436

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James & Associates's CANO Position: Q4 2023 in Review

Raymond James & Associates sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 1,166 shares — an estimated $29.6K sold.

Raymond James & Associates first reported a position in CANO in Q4 2020 and held it in 12 quarters. The position peaked at $1.25M in Q3 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Raymond James & Associates reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 1,166 Cano Health, Inc. shares in Q4 2023, an estimated $29.6K.
  • Raymond James & Associates first reported a position in Cano Health, Inc. in Q4 2020 and held it in 12 quarters.
  • Raymond James & Associates's Cano Health, Inc. position peaked at $1.25M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.